PT  - JOURNAL ARTICLE
AU  - Almeda, Alison F
AU  - Grimes, Sue
AU  - Lee, HoJoon
AU  - Greer, Stephanie U
AU  - Shin, GiWon
AU  - McNamara, Madeline
AU  - Hooker, Anna C
AU  - Arce, Maya
AU  - Kubit, Matthew
AU  - Schauer, Marie
AU  - Van Hummelen, Paul
AU  - Ma, Cindy
AU  - Mills, Meredith
AU  - Huang, Robert J
AU  - Hwang, Joo Ha
AU  - Amieva, Manuel R
AU  - Han, Summer
AU  - Ford, James M.
AU  - Ji, Hanlee P.
TI  - The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Stomach Malignancies
AID  - 10.1101/2022.03.10.22271914
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.10.22271914
4099  - http://medrxiv.org/content/early/2022/03/13/2022.03.10.22271914.short
4100  - http://medrxiv.org/content/early/2022/03/13/2022.03.10.22271914.full
AB  - Background Gastric cancer (GC) is a leading cause of global cancer morbidity and mortality. Developing information systems which integrate clinical and genomic data may accelerate discoveries to improve cancer prevention, detection, and treatment. To support translational research in GC, we developed the GC Registry (GCR), a North American repository of clinical and cancer genomics data.Methods GCR is a national registry with online self-enrollment. Entry criteria into the GCR included the following: (1) diagnosis of GC, (2) history of GC in a first-or second-degree family member or (3) known pathogenic or likely pathogenic germline mutation in the gene CDH1. Participants provided demographic and clinical information through a detailed (412-item) online survey. A subset of participants provided specimens of saliva and tumor samples. These tumor samples underwent exome sequencing, whole genome sequencing and transcriptome sequencing.Results From 2011-2021, 567 individuals registered for the GCR and returned the clinical questionnaire. For this cohort 65% had a personal history of GC, 36% reported a family history of GC and 14% had a germline CDH1 mutation. Eighty-nine GC patients provided tumor tissue samples. For the initial pilot study, 41 tumors were sequenced using next generation sequencing. The data was analyzed for cancer mutations, copy number variations, gene expression, microbiome presence, neoantigens, immune infiltrates, and other features. We developed a searchable, web-based interface (the GCR Genome Explorer) to enable researchers access to these datasets.Conclusions The GCR is a unique, North American GC registry which integrates both clinical and genomic annotation.Impact Available for researchers through an open access, web-based explorer, we hope the GCR Genome Explorer accelerates collaborative GC research across the United States.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was supported by the Gastric Cancer Foundation. Additional support to HPJ came from the Research Scholar Grant, RSG-13-297-01-TBG from the American Cancer Society, and the Clayville Foundation. RJH is supported by the National Cancer Institute of the National Institutes of Health under Award Number K08CA252635.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Stanford University gave ethical approval of this work (IRB-20285).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPrimary data is available on the Gastric Genome Explorer website (https://gcregistry-explorer.stanford.edu/). Other data generated in this study are available within the article and its supplementary files. https://gcregistry-explorer.stanford.edu/ GCGastric cancerGCRGastric Cancer RegistryFFPEFormalin fixed paraffin embeddedRNA-seqRNA sequencingHLAHuman leukocyte antigenTCGAThe Cancer Genome AtlasSTADStomach adenocarcinomaESCAEsophageal carcinomaStoPStomach Cancer Pooling Project